Ardent Health, Inc. ARDT
Set alert
11.67 USD -0.06 -0.51%
As of Nov 3, 1:02 PM ET
11.55 Day range 11.75
7.83 52-week range 14.68
- YTD
- +32.16%
- 1 year
- -20.50%
- Open
- 11.59
- Prev close
- 11.73
- Mkt cap
- 1.65B
- Vol
- 77.55K
- Avg vol
- 430.62K
- EPS
- 0.54
- P/E
- 21.61
- Div yield
- 0.00%
More statistics
- Low
- 11.55
- High
- 11.75
- Forward P/E
- 9.34
- Beta
- 0.58
- Short ratio
- 7.62
- Inst. own
- 76.75%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 11.16
- 200-d avg
- 9.98
- 1y target
- 12.67
Analyst view
Consensus: buy
Buy
Price target (mean) 12.67 +8.5% upside
Now 11.67
- Target (low)
- 10.50
- Target (mean)
- 12.67
- Target (high)
- 14.00
Ratings (0m) 13 7 buy · 5 hold · 1 sell
- Strong buy1
- Buy6
- Hold5
- Sell0
- Strong sell1
Recommendation trend
- This month 13
- 1 month ago 13
- 2 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.245 | 0.13 – 0.34 | 0.8307 | -70.5% | 1.60B | +1.7% | 4 |
| Next quarter | 0.345 | 0.28 – 0.43 | 0.3636 | -5.1% | 1.63B | +1.7% | 4 |
| Current year | 1.09 | 0.81 – 1.56 | 1.54 | -29.6% | 6.46B | +2.2% | 4 |
| Next year | 1.26 | 1.09 – 1.49 | 1.09 | +15.4% | 6.73B | +4.1% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 23, 2026 | BMO Capital | Initiated | — | Market Perform |
| Sep 18, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Aug 10, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 6, 2026 | Truist Securities | Maintained | Buy | Buy |
| Aug 6, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 14, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 9, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 7, 2026 | UBS | Maintained | Buy | Buy |
| Mar 10, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Mar 6, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Jan 20, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Dec 18, 2025 | UBS | Maintained | Buy | Buy |
| Dec 18, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Nov 24, 2025 | JP Morgan | Maintained | Neutral | Neutral |
| Nov 18, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Nov 18, 2025 | Guggenheim | Maintained | Buy | Buy |
| Nov 17, 2025 | Keybanc | Downgrade | Overweight | Sector Weight |
| Nov 14, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 14, 2025 | Truist Securities | Maintained | Buy | Buy |
| Nov 14, 2025 | Stephens & Co. | Maintained | Overweight | Overweight |
| Nov 14, 2025 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Nov 13, 2025 | B of A Securities | Maintained | Underperform | Underperform |
| Oct 14, 2025 | Goldman Sachs | Initiated | — | Neutral |
| Sep 10, 2025 | UBS | Initiated | — | Buy |
| Aug 11, 2025 | JP Morgan | Maintained | Neutral | Neutral |
| Aug 7, 2025 | Keybanc | Maintained | Overweight | Overweight |
| Jul 16, 2025 | B of A Securities | Downgrade | Neutral | Underperform |
| May 20, 2025 | Stephens & Co. | Reiterated | Overweight | Overweight |
| May 15, 2025 | RBC Capital | Reiterated | Outperform | Outperform |
| May 9, 2025 | Guggenheim | Maintained | Buy | Buy |